Kanał TLRY
TL

Tilray Brands, Inc.

TLRY · NASDAQ

$4.08 +1.49% (+$0.06)
1M -15.47%
Market Cap $440.6M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9
Valuation
44 /100
Fair
EV/EBITDA 37.81x
P/S 0.38x
P/B 0.27x
Growth
26 /100
Declining
Rev. growth 2.72%
Book val. growth 28.77%
EPS growth N/A
Profitability
10 /100
Weak
Gross margin 27.57%
Net margin 12.90%
Op. margin 5.18%
Quality
6 /100
Poor
ROIC 3.46%
ROE 7.95%
ROA 6.40%
Debt
45 /100
Moderate
Debt/Equity 0.25x
Current ratio 2.21x
Int. coverage -2.31x
Stability
15 /100
Unstable
Beta 1.92x
Rev. volatility 23.02%
EPS volatility 428.66%

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o TLRY
Online

O spółce

Tilray Brands, Inc. is an international company specializing in the production and distribution of medicinal cannabis products and related goods. The company focuses on the cultivation, processing, and manufacturing of medical cannabis with an emphasis on quality and safety. Tilray Brands offers various forms of cannabis products, including therapeutic oil, capsules, flowers, and other preparations designed for medicinal purposes. The company collaborates with physicians and patients to provide high-quality and effective treatment options for various medical conditions. Tilray Brands is also engaged in research and development of new cannabis medicines and therapies. The company is following the growing interest in medicinal cannabis and its potential to improve the health of patients. Tilray Brands, Inc. (TLRY or TLB) shares could be an interesting choice for investors who follow the market for medicinal cannabis products and seek investment opportunities in an international company with a specialized focus on medical cannabis.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Irwin David Simon

Employees

3,595

Headquarters

Leamington

Nadchodzące wydarzenia

08 PAŹ

Earnings

Upcoming earnings report

17d

Używamy niezbędnych plików cookie do działania strony oraz opcjonalnych analitycznych plików cookie do pomiaru ruchu. Zobacz naszą Politykę prywatności.